Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Cyclo Therapeutics

CYTH

0.72060.00% ( 0.0000 )

Delisted: Sep 3, 09:20:00 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Cyclo Therapeutics (CYTH)

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerati...

Open: --
High: --
Low: --
Prev. Close: 0.7206
Volume: 0
Turnover: 0
Avg Price: --
Bid/Ask Ratio: --
Amplitude: --
52wk High: --
Volume Ratio: 0.00
Turnover Ratio: --

52wk Low: --
Float Mkt Cap: 8.30M
Market Cap^USD: 20.73M
P/E^TTM: Loss
P/E^Dynamic: Loss
P/E^Static: --
EPS^TTM: -0.917
EPS^Dynamic: -0.892
EPS^Static: --
BVPS: -0.47
P/B: --
Circulating Supply: 11.51M
Dividend Yield^TTM: --
Dividend^TTM: --
Shares: 28.77M
Min lot size: 1
Currency: USD

News

Unusual Whales · Feb 17 at 01:36 PM
Cyrano Therapeutics reports successful Phase 2 trial of CYR-064 for smell loss, advancing to Phase 3 in 2H 20206.
GlobeNewswire · Oct 29, 2025 at 09:07 PM
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results